St. Louis, MO, United States of America

Galera Therapeutics, LLC


USPTO Granted Patents = 5

% Expired Patents = 100.0


Trademarks = 3

Forward Citations = 51

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Dennis Patrick Riley (4 out of 62 patents)

silverMedal Urszula Slomczynska (3 out of 27 patents)

bronzeMedal Bobby N Trawick (3 out of 18 patents)

4.  Arati Naik (3 out of 4 patents)

5.  Daniela Salvemini (1 out of 16 patents)

6.  Kishore Udipi (1 out of 41 patents)

7.  Amruta Reddy Poreddy (1 out of 7 patents)

8.  Samuel J Tremont (1 out of 45 patents)

9.  William L Neumann (1 out of 57 patents)

10.  Jeffery L Keene (13 patents)

11.  Urszula J Slomczynska (0 patent)

12.  Denis P Riley (0 patent)

13.  Robert A Beardsley (0 patent)


5 patents:

Company Overview
Galera Therapeutics, LLC is a clinical-stage biopharmaceutical company focused on developing innovative therapies to address the unmet needs of patients suffering from cancer treatment-related toxicities. The company's lead product candidate, GC4419, is being evaluated for the prevention of oral mucositis in patients undergoing radiation therapy for head and neck cancer. Galera Therapeutics is dedicated to improving the quality of life for cancer patients through its cutting-edge research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#292 in St. Louis, MO

#729 in Missouri

#51,620 in US

St. Louis, MO (US)
St. Louis, MO, United States of America
Forward Citations = 51

9 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Galera Therapeutics, LLC. Retrieved from https://idiyas.com/company/galera-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…